You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Molecules Banner
Commercial Manufacturing of Autologous Muscle Derived Cell ( ... Image 1

Commercial Manufacturing of Autologous Muscle Derived Cell (AMDC) products

Challenge from the Client

Multiple challenges were presented for this effort. Primary challenges involved:

  • Renovation of an existing manufacturing facility, 
  • Demonstrating that the facility, systems and equipment were fit for intended use for compliant commercial manufacturing operations through application of a comprehensive commissioning and qualification program.
  • Providing program management, compliance, and project controls support for a multi-faceted, facility renovation project.
  • Providing compliance, design, and project delivery consulting support to assist in transition from a capital project environment to CGMP-compliant commercial manufacturing operations for AMDC products.
  • Providing SME-level analysis and evaluations of manufacturing processes, process tickets, and support systems to identify potential gaps & needs for transitioning current manufacturing operations from preclinical- and clinical-scale, to fully CGMP-compliant commercial manufacturing operations.

Our Approach & Solution

The IPS team applied expert industry knowledge and skills to deliver value to this effort. We provided coaching in many areas to help align procedures, templates, deliverables and activities with current industry practice and guidance.

The Results

This ongoing collection of projects will continue through multiple years. Projects include:

  • Site CGMP and design assessments of the commercial manufacturing facility, systems and equipment and recommendations for remediation
  • Laboratory commissioning 
  • Site CGMP assessment of the preclinical & clinical manufacturing facility, systems and equipment and recommendations for remediation
  • Development of URS's, GMP impact assessments, and maintenance & calibration work instructions for production and lab equipment in the preclinical & clinical manufacturing facility
  • Manufacturing Process Quality Risk Assessment  
  • Compliance support (Commissioning, Qualification, Validation) for the commercial manufacturing facility, involving 1250 documents and 450 test execution activities supporting:
    • Building Management Systems
    • Warehouse and Logistics areas
    • Laboratories
    • Manufacturing
    • Facility and utilities

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue